Smith & Nephew Says Olivier Bohuon To Remain CEO During Cancer Treatment Period

(RTTNews) - Smith & Nephew Plc. (SN.L, SNN), a medical technology company, Monday announced that its Chief Executive Officer Olivier Bohuon has been diagnosed with a highly treatable form of cancer.

Bohuon will remain Chief Executive Officer and be actively involved in running the Company through much of his treatment period, which will begin later this month. The treatment will include chemotherapy, and is expected to be completed by late autumn. The company said its Board has approved provisional governance procedures to ensure its effective operation during the treatment period, including Chairman Roberto Quarta providing executive oversight if required. Quarta said, "Olivier has set a clear strategy that is invigorating Smith & Nephew's growth profile. I am confident that Olivier and his team will continue to execute the plan successfully. Our thoughts are with him as he undergoes treatment." Bohuon will present Smith & Nephew's fourth quarter results on February 4.